Evogene Ltd.
EVGN- Exchange
- Nasdaq
- Industry
- Agricultural Chemicals
- SEC CIK
- 0001574565
In the last 90 days, Evogene Ltd. insiders filed 3 open-market purchases and 0 sales; 13 institutions reported holding it in 13F filings for Q2 2026, worth $120.0K in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding Evogene Ltd. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 46 | 44 | −2 |
| Shares | 8.36M | 7.41M | −955.2K (−11.4%) |
| Value | $42.1M | $25.3M | −$16.8M (−39.9%) |
New holders (7)
Institutions that held Evogene Ltd. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Renaissance Technologies LLC | 95,800 | $328.0K | 0.00% |
| Susquehanna International Group Ltd. | 28,143 | $96.0K | 0.03% |
| Occudo Quantitative Strategies LP | 27,481 | $94.0K | 0.01% |
| XTX Topco Ltd | 21,169 | $72.0K | 0.02% |
| SNS Financial Group, LLC | 10,000 | $34.0K | 0.00% |
| Tower Research Capital LLC (TRC) | 912 | $3.00K | 0.00% |
| FMR LLC | 1 | $0 | 0.00% |
Sold out (9)
Institutions that held Evogene Ltd. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Marshall Wace North America L.P. | 39,610 | $200.0K |
| Trexquant Investment LP | 33,243 | $168.0K |
| HRT Financial LP | 15,043 | $75.0K |
| Marshall Wace, LLP | 12,872 | $65.0K |
| Raymond James Financial Services Advisors, Inc. | 10,075 | $51.0K |
| Citigroup Inc | 7,350 | $34.0K |
| Advisory Services Network, LLC | 4,000 | $20.0K |
| Sowell Financial Services LLC | 345 | $1.00K |
| Group One Trading, L.P. | 81 | $0 |